Potentiation of the Uricosuric Effect of Dotinurad by Trans-Inhibition of the Uric Acid Reabsorptive Transporter URAT1

Kazuki Fujita; Qiunan Zhu; Hiroshi Arakawa; Yoshiyuki Shirasaka; Ikumi Tamai

doi:10.1124/dmd.123.001412

OtherArticle

Potentiation of the Uricosuric Effect of Dotinurad by Trans-Inhibition of the Uric Acid Reabsorptive Transporter URAT1

Kazuki Fujita, Qiunan Zhu, Hiroshi Arakawa, Yoshiyuki Shirasaka and Ikumi Tamai

Drug Metabolism and Disposition August 29, 2023, DMD-AR-2023-001412; DOI: https://doi.org/10.1124/dmd.123.001412

Kazuki Fujita

1Kanazawa University, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Qiunan Zhu

1Kanazawa University, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Qiunan Zhu

Hiroshi Arakawa

2Faculty of Pharmacy, Kanazawa University, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hiroshi Arakawa

Yoshiyuki Shirasaka

3Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ikumi Tamai

4Facylty of Pharmaceutical Sciences, Kanazawa University, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ikumi Tamai
For correspondence: tamai@p.kanazawa-u.ac.jp

Article
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Drug Metabolism and Disposition

Vol. 51, Issue 10

1 Oct 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Potentiation of the Uricosuric Effect of Dotinurad by Trans-Inhibition of the Uric Acid Reabsorptive Transporter URAT1

Message Subject (Your Name) has forwarded a page to you from Drug Metabolism & Disposition

Message Body (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherArticle

Trans-inhibition of uric acid transporter URAT1 by dotinurad

Kazuki Fujita, Qiunan Zhu, Hiroshi Arakawa, Yoshiyuki Shirasaka and Ikumi Tamai

Drug Metabolism and Disposition August 29, 2023, DMD-AR-2023-001412; DOI: https://doi.org/10.1124/dmd.123.001412

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherArticle

Trans-inhibition of uric acid transporter URAT1 by dotinurad

Kazuki Fujita, Qiunan Zhu, Hiroshi Arakawa, Yoshiyuki Shirasaka and Ikumi Tamai

Drug Metabolism and Disposition August 29, 2023, DMD-AR-2023-001412; DOI: https://doi.org/10.1124/dmd.123.001412

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Potentiation of the Uricosuric Effect of Dotinurad by Trans-Inhibition of the Uric Acid Reabsorptive Transporter URAT1

Plain text

Vertical Tabs

Jump to comment:

In this issue

Trans-inhibition of uric acid transporter URAT1 by dotinurad

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals